Form 4: Agenus Inc. CEO Garo Armen Receives Stock in Lieu of Cash Salary
SEC Form 4 Filing
Agenus Inc. CEO Garo Armen received 2,486 shares of common stock in lieu of cash salary for the pay period ending July 26, 2024, at a price of $6.56 per share.
Summary
- Garo H. Armen, CEO of Agenus Inc., received 2,486 shares of Agenus common stock on July 26, 2024, as payment for his salary in lieu of cash.
- The stock was issued at a price of $6.56 per share, which was the closing price of Agenus common stock on that date.
- The shares were issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive and are fully vested upon issuance.
- Following the transaction, Armen directly owns 79,147 shares.
- Armen also indirectly owns 31,298 shares through his IRA accounts and 28,950 shares as trustee and general partner.
Sentiment
Score: 6
Explanation: Neutral sentiment as it reports a standard executive compensation transaction. The decision to take salary in stock could be viewed positively, but it's not a strong indicator of future performance.
Positives
- The CEO's decision to take salary in stock may signal confidence in the company's future performance.
- The stock was issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive and are fully vested upon issuance.
Industry Context
This type of transaction, where executives take salary in stock, is not uncommon in the biotech industry, especially for companies focused on long-term growth.
Comparison to Industry Standards
- Executive compensation packages often include stock options or grants to align management's interests with those of shareholders.
- The specific amount and vesting schedule of these grants vary widely based on company size, performance, and industry norms.
- Comparing Agenus' executive compensation structure to that of similar-sized biotech companies would provide a more comprehensive assessment.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it slightly increases the number of outstanding shares.
- Employees may view the CEO's decision to take salary in stock as a positive sign of confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 07/26/2024 | Date of transaction: Garo Armen received stock in lieu of cash salary. |
| 07/26/2024 | Payroll date for the pay period ending July 26, 2024. |
| 07/29/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.